Aurinia Pharmaceuticals
AUPH
AUPH
190 hedge funds and large institutions have $221M invested in Aurinia Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.04% less ownership
Funds ownership: 39% → 35.96% (-3%)
47% less capital invested
Capital invested by funds: $416M → $221M (-$195M)
Holders
190
Holding in Top 10
1
Calls
$11.5M
Puts
$5.52M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$9.43M | |
| 3 | +$5.29M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.44M |
| 5 |
Renaissance Technologies
New York
|
+$3.97M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$21.6M | |
| 3 | -$6.72M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$2.78M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.55M |